NovMetaPharma
Gangneung
About NovMetaPharma
Nov Metaphora Co., Ltd. is a company that develops and sells new drugs related to metabolic disease, which is the biggest threat of healthy life due to population aging and changes in eating habits, As a company, they expect the company to achieve 1) growth potential and profitability in the market for metabolic disease treatment products, 2) alternative antidiabetic agents with improved antidiabetic efficacy (insulin resistance improvement) due to the concentration of simple blood glucose control functions in existing diabetes drugs and reports of side effects of existing insulin sensitivity enhancers The need for development 3) One of the world's leading research institutes in the field of metabolic diseases, it has developed into a global pharmaceutical company by commercializing the research results and original technology acquired through cooperation with the VA Institute (Department of Veterans Affairs, Greater Los Angeles Healthcare System) Has been established to.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Last round: Series Unknown (Jan 2014)
- Website: novmeta.com
- Phone: 02-538-1893
Industries & Categories
Health Care, Pharmaceutical, Wholesale
Canonical: https://fsome.com/organization/novmetapharma-2807095 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.